MITSUO KITAHARA, M.D.; THOMAS M. COSGRIFF, M.D.; HARMON J. EYRE, M.D.
Sideroblastic anemia after treatment for Hodgkin's disease was seen in two patients 3 years after completion of radiation therapy and chemotherapy. This was followed in both by the development of myelomonoblastic leukemia. No evidence of recurrent Hodgkin's disease was present in either patient. Our observation suggests that development of sideroblastic anemia in patients previously treated for Hodgkin's disease is probably secondary to the treatment and is a preleukemic event.
Learn more about subscription options.
Register Now for a free account.
KITAHARA M, COSGRIFF TM, EYRE HJ. Sideroblastic Anemia as a Preleukemic Event in Patients Treated for Hodgkin's Disease. Ann Intern Med. 1980;92:625–627. doi: 10.7326/0003-4819-92-5-625
Download citation file:
Published: Ann Intern Med. 1980;92(5):625-627.
Hematology/Oncology, Leukemia/Lymphoma, Red Cell Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only